Wellcome Trust logo
Wellcome Trust

Wellcome Infectious Disease Clinical Trial Award

Funds clinical trial teams in low and middle income settings to test infectious disease interventions effectively.

ClosedWellcome TrustDZAOBJBWBFBICMCVCFTDKMCDCGCIDJEgyptGQERSZEthiopiaGAGMGhanaGNGWKenyaLSLRLYMGMWMLMRMUMoroccoMZNENigeriaRwandaSTSenegalSLSOSouth AfricaSSSDTanzaniaTGTunisiaUgandaZMZWAFBangladeshBTIndiaMVNPPakistanSri LankaKHIndonesiaLAMalaysiaMMPhilippinesThailandTLVietnam

The Wellcome Infectious Disease Clinical Trial Award is a one-off competitive call administered by Wellcome Trust in partnership with the UK's National Institute for Health and Care Research (NIHR), using official UK international development funding. The award supports transdisciplinary teams to conduct randomised controlled trials (RCTs) optimising licensed pharmaceutical interventions for speciโ€ฆ

Randomised controlled trials optimising licensed pharmaceutical interventions for specified infectious diseases โ€” including mycobacterial infections, bacterial infections, invasive fungal infections, dengue, leishmaniasis, and schistosomiasis โ€” led from Africa, South Asia, or South-East Asia.

CycleiHow often this grant runs - e.g. annually, on a rolling basis, or a one-off call.One-off
Next deadlineiThe next date applications are due. Rolling means you can apply any time.-
Decision timeiTypical time from the deadline to the funder's decision.-
Project durationiHow long the funded work is expected to run.36โ€“60 months
Award typeiThe form of funding - grant, equity, loan, tax credit, etc.Grant
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.0%
Funding pooliThe total budget available across all awards in this round.-

Sign up free to see the funding breakdown

Sign up free to see the industries in scope

Sign up free to see the full eligibility

Sign up free to see how to apply

Sign up free to see what you submit

Sign up free to see the timeline

Sign up free to see where teams trip up

Guides for this application

All guides โ†’
European Commission logo
Scheduled

Clinical trials for advancing innovative interventions for neurodegenerative diseases

๐Ÿ‡ช๐Ÿ‡บEuropean Commission ยท European Union

Funds early clinical trials of safer, more effective interventions for non-rare neurodegenerative diseases.

MedtechBiotech
โ‚ฌ10MApr'27
European Commission logo
Scheduled

Clinical Research for Common Cancers

๐Ÿ‡ช๐Ÿ‡บEuropean Commission ยท European Union

Funds โ‚ฌ7โ€“10M programmes that bring better cancer diagnosis and treatment trials to patients across four or more European countries.

MedtechBiotech+1
โ‚ฌ7M โ€“ โ‚ฌ10MSep'27
European Commission logo
Scheduled

Personalised approaches to reduce risks from adverse drug reactions due to multiple medications

๐Ÿ‡ช๐Ÿ‡บEuropean Commission ยท European Union

Funds safer medication management using biomarkers, clinical data and decision support.

MedtechBiotech+1
โ‚ฌ8M โ€“ โ‚ฌ10MApr'27
European Commission logo
Scheduled

Pre-Commercial Procurement for Cancer Care

๐Ÿ‡ช๐Ÿ‡บEuropean Commission ยท European Union

Funds โ‚ฌ8โ€“10M procurer consortia to bring affordable cancer technologies, devices and medicines from tender to patient benefit.

MedtechBiotech+1
โ‚ฌ8M โ€“ โ‚ฌ10MSep'27
European Commission logo
Scheduled

Innovative Antimicrobials Against Resistant Pathogens

๐Ÿ‡ช๐Ÿ‡บEuropean Commission ยท European Union

Funds antibacterial and antifungal therapies that expand treatment options against antimicrobial-resistant infections.

BiotechMedtech
โ‚ฌ8M โ€“ โ‚ฌ10MApr'27
European Commission logo
Scheduled

Mission Soil and Cancer: Living Labs for Carcinogenic Contamination

๐Ÿ‡ช๐Ÿ‡บEuropean Commission ยท European Union

Funds two โ‚ฌ12M projects using living labs to remediate carcinogenic soils and trace cancer risks through people, food, water and air.

Climate TechMedtech+2
โ‚ฌ12MSep'27